Vascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

Similar documents
KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

ASDIN 7th Annual Scientific Meeting

Pitfalls in pushing fistulas ----

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Preservation of Veins and Timing for Vascular Access

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Jimmy Wei Hwa Tan, Surg, MD

Vascular Access for Haemodialysis. Mike Stephens

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Hemodialysis Fistula Maturation Consortium

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

Medical Director/Surgeon as Partners WebEx February 11, 2010

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Incident Hemodialysis

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

NKF K/DOQI GUIDELINES

Difference in practical dialysis therapy between East Asia and US/EU

Il paziente anziano, evidenza e survey nazionale

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Steal Syndrome: The Role of the Vascular Lab

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Utopia Health Career Center, LLC. Do not distribute without permission.

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS

ASDIN 8th Annual Scientific Meeting

The vexing problem of suboptimal initiation of dialysis: Can we do better?

HD Scanning: Velocities and Volume Flow

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Lutonix in AV fistula and Early look AV IDE trial data

JVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Explorations fonctionnelles des abords vasculaires pour hémodialyse

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation

First experience with DCB for treatment of dialysis access stenosis The Greek experience

Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance

Chapter 2 Proximal Forearm Arteriovenous Fistula Creation

Focus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba

Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Role of Covered Stents and Drug Eluting Balloons In Dialysis Access


Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system

REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange

Regardless of whether you are a vascular surgeon,

Bare Metal Stents vs Stent Grafts

Internationally, the arteriovenous fistula (AVF)

Vascular Access for Patients affected by non Renal Disorders. Eric S Chemla St George s vascular Institute London UK

LUTONIX AV Clinical Trial

*PTA Failure: Recoil >30% stenosis or more than 2 PTA s within 3 mo. Bart Dolmatch, MD

Cephalic Arch Stenosis: A unique entity

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Chapter Five Clinical indicators & preventive health

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

COVERA Vascular Covered Stents Innovation in AV Access

Supera for the Juxta-anastomotic AVF Stenosis

Evaluation of AVF and AVG

Anesthetic Options for Patients Undergoing Dialysis Access Procedures Derek T. Woodrum, M.D. University of Michigan Hospitals, Ann Arbor, MI

Early adopters and clinical investigators of percutaneous. The SIR 2016 Panel on Endovascular Arteriovenous Fistula Creation

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Omniflow II biosynthetic vascular prosthesis

De dialysefistel: snel maken, snel staken? Joris Rotmans, internist-nefroloog Afdeling Interne Geneeskunde Leids Universitair Medisch Centrum

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital

Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis

Selection of Permanent Hemodialysis Vascular Access

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Endovascular Should Be Considered First Line Therapy

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Lutonix AV Clinical Trial

Brachial vein transposition arteriovenous fistulas for hemodialysis access

Vein diameter is the major predictor of fistula maturation

USRDS UNITED STATES RENAL DATA SYSTEM

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Time to Reduce Mortality in End Stage Renal Disease (TiME)

Experience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group. Nehad Zaid

4/30/2014. In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

Lutonix AV Clinical Trial

Coding of Procedures in Interventional Nephrology Produced in collaboration with:

Transcription:

Vascular Access creation in the US A surgical perspective Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

Disclosures No specific disclosures pertaining to the topic of presentation

Vascular Access in US Surgical perspective.. Background 50 th Anniverseryof Internal (access) shunts Cimino Appel Brescia Brescia XXX Cimino XXX Appel XXX Cimino Appel Brescia Brescia MJ, Cimino JE, Appel K, Hrwich BJ NEJY;1966:1089

Vascular Access in US Surgical perspective Background Health care changes in US: Impact on VA Social Security Amendments 1972 All persons with ESRD eligible for medicare Assured reimbursement Improved access to healthcare Increased experience better care and longevity Physician s Behavioral change Patient profile: elderly, diabetics, co morbidities Beneficiaries 10,000 (1970) to >150,000 (1990) USRDS ADR Ch XII 1994

Vascular Access in US Surgical perspective. Fistulae better than shunts Need for anatomic suitability Maturation period Uncertainty of success Biologic Xenografts Cross linked 1972 - Bovine carotid artery (Artegraft, Artegraft Inc) AVF Background Problems with vascular access Cross link Non cross linked non antigenic AVG Allograft 1978 - Human Umbilical vein (Biograft, Meadox Meds) - Saphenous vein Synthetic 1976 Non cross linked - eptfe Cryopreserved (1985) antigenic Multitudes of sites with very little technical changes Snuff box, high & low wrist fistula, brachiocephalic, Gracz AVF, basilica transposition UA, basilic transposition FA No attention paid to cause of failure no need due to short longevity

Vascular Access in US Surgical perspective. Background US ESRD population (200,000) Japan ESRD (175,00) European ESRD (30,000) NKF-KDOQI (1995) Fistula First (2003) ~ 80% AVG ~ 85% AVF ~ 80% AVF Access population differences Access modality differences Outcome differences Goodkin DA et.al. JASN 2003; 14: 3270 Schena FP Kidney Int 2000; 57: S39-45

Strategies to improve ESRD mortality Decreased BP Decreased LVH (2000-present) RAS inhibitors, statins, BP control, Phos control, fluid control etc. Increased dialysis dose Improved QOL Phos control Quality of dialysis depends on functioning of vascular access AVG, Catheters and AVF Better nutrition Williams AW. AJKD 2004;43:90 Kliger AS. CJASN 2009;4:S121

Vascular access practice patterns Access performed by well-trained surgeons Surgeons trained in graft era Minimal experience in AVF Access = joining a vein/graft to artery High rates of primary failure TDC prevalence Origin and proliferation of image guided procedures and devices and catheter industry Adaptation of medical community to changing practice pattern Dember LM et.al. JAMA 2008;299:2164-71 Lacson E, et.al. AJKD 2007; 50:379-95

Individual data AVF 79% AVG 21% Functional AVF maturation 81.7% Committed to catheter 3.5% AVF maturation (ITT) 72% 1 yr. Primary patency 42.5% 1 yr. Secondary patency 81.8 % Median (range 1.2-97.7 mon) followup 36.1 mon AVF procedures per functional year 0.68 Patient outcome >85% AVF

VA creation: Changing outcome Richardson AI et.al. JVA 2009; 10: 199-02 Dember LM et.al. JAMA 2008;299:2164-71 Jennings WC. Arc Surg 2006; 141:27-32 Lucas J. J Vasc Surg 2016;

VA surgical practice patterns Large Academic Medical center ~ 300 cases in 1 year by 8 surgeons 2 Surgeons performed >60% of procedures These surgeons performed >80% AVF One recent trainee also performed >80% AVF Other surgeons performed AVF ~ 50% patients Patterns reflect a changing practice patterns showing improvement in training and importance of access champions Vachharajani N,et.al. J Vasc Surg 2015: s1-s4

VA patterns in incident patients CMS 2728 & crown web data 2013 Catheter 20% 80% 17% AVF 65% USRDS 2015

Vascular access surgical training Vascular Board certification data 300% increase in AVF (5 in 2003 to 18) VA is considered a resident case 19 residents graduated between 2012-2014 Required vascular cases 44 Average AVF/AVG(range 11-73) 33 Revisions (range 1-27) 11 Trainees interested in VA 62 Eidt JF. JVS 2011; 53: 1130-40 Current surgical training provides ample opportunity Vachharajani N,et.al. J Vasc Surg 2015: s1-s4

What are some issues? Difficulty to make AVA attractive High rates of failure Lack of scientific understanding Lack of innovative research Multidisciplinary nature of the practice Fragmentation of care Lack of advocacy

Physiology: AVA maturation & failure Central outflow Capacity of the pump diameter, stiffness & length of the tubes determines the flow Inflow Peripheral Outflow NAS (Needle access Segment) AVG is NAS of the circuit Stenosis is the cause for majority of access circuit failure

Where we are now? Total ESRD population ~661,648 Hemodialysis (91%) ~421,000 Peritoneal Dialysis (9%) ~ 45,000 Post transplant ~ 193,000 ~ 117,000 patients started dialysis in 2012 Growing patient population will propel changes in the field USRDS 2015

Summary Surgical problems associated with vascular access were part of the evolution of the speciality. The current eduction system is robust enough to adjust the need of the changing practice patterns. There is a need for better understanding and research in the field to improve the current outcome Increasing prevalence of ESRD will continue to fuel the progress and innovation

Vascular Access creation in the US A surgical perspective